From
StayCurrentMD
How Many Lymph Nodes are Enough in Paratesticular Rhabdomyosarcoma?
Part of
Pediatric Oncology 696 items
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Oct 2024 · 1 min read
In brief
In brief
This study evaluates optimal lymph node sampling requirements for accurate staging in paratesticular rhabdomyosarcoma, a pediatric genitourinary sarcoma. Using advanced statistical methodology, researchers quantify the risk of missing metastatic disease based on lymph node yield, challenging current staging recommendations.
- Accurate lymph node evaluation is critical for staging paratesticular rhabdomyosarcoma and determining appropriate treatment strategies.
- Current LN sampling recommendations may be inadequate as they don't account for inter-patient variability or relationships between nodes.
- Higher lymph node yield reduces the probability of missing occult nodal metastases in PT RMS staging procedures.
- Traditional methods based solely on positivity rates may underestimate the number of nodes needed for accurate staging.
- Optimal LN yield thresholds should be established using methodology that accounts for patient-level and node-level relationships.
Written by the GCMD Library team from the article.
Treatment strategies for paratesticular rhabdomyosarcoma (PT RMS) are based on stage, which requires accurate lymph node (LN) evaluation. Previous methodology for determining quantity of LN for negative nodal status is based on LN positivity rates, without accounting for the relationship between LNs or amongst patients. This study aims to quantify the chance of missing involved LNs based on LN yield (LNY) using a previously established methodology in comparison to current recommendations.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Oncology Tumor Board Showdown: Pediatric Oncology 5 Question Quiz
1 min · Published Oct 2026
Article
Minimally invasive surgery for abdominal and thoracic neuroblastic tumors: A systematic review by the APSA Cancer committee
Juan Pablo Gurria · Published Oct 2026
Video
Clinical & Research Update: Renal Tumors with Drs. Ethan Smith, Lindsay Haacker, Michael Daugherty, and Meera Kotagal
71 min · Published Sep 2026
Video
Clinical & Research Update: Neuroblastoma with Drs. Katherine Somers, Cara Morin, Juan Gurria, and Meera Kotagal
67 min · Published Sep 2026
Video
Clinical & Research Update: Sarcoma w/ Drs. Roshni Dasgupta, Joseph Pressey, Arthur Meyer, Luke Pater
66 min · Published Sep 2026
Video
Update Course Rewind 2025: Nerve Monitoring in Pediatric Thyroid Surgery
6 min · Published Jul 2026
Video
Intestinal Atresia Types Explained: Grossfeld Classification for Pediatric Surgery
1 min · Published Sep 2026
Video
Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study
50 s · Published Sep 2026
Video
FETO for Late-Diagnosed Severe Congenital Diaphragmatic Hernia (CDH) at Cincinnati Children's with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Severe Congenital Diaphragmatic Hernia (CDH) Case: FETO Management & Unexpected Findings with Dr. Beth Rymeski
3 min · Published Sep 2026
Video
Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure: Step-by-Step Guide with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Choledochal Cyst Types Explained: Pediatric Surgery Fundamentals
1 min · Published Sep 2026
